Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet.
Boltz has raised $28 million in fresh funding while entering a strategic partnership with Pfizer that underscores the accelerating push by major drugmakers to embed artificial intelligence deeper into ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results